(MENAFN- Straits Research)
Positive Airway Pressure Devices Market Size & Growth Analysis
The global positive airway pressure devices market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.06 billion in 2026 to USD 4.66 billion by 2034, registering a CAGR of 5.4% during the forecast period from 2026 to 2034. North America dominated the positive airway pressure devices market with a market share of 42.5% in 2025.
Positive airway pressure devices are medical devices that deliver pressurized air through a mask to keep the airway open and support breathing. Common types include continuous positive airway pressure (CPAP), automatic positive airway pressure (APAP), and bilevel positive airway pressure (BiPAP). These devices are widely used to manage sleep apnea and other breathing disorders.
Positive Airway Pressure Devices Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 2.90 Billion
2026 Market Size: USD 3.06 Billion
2034 Projected Market Size: USD 4.66 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 5.4%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 42.5%
Fastest-Growing Region: Asia Pacific
Asia Pacific CAGR (2026–2034): 8.2%
Segment Insights
By Product Type
Leading Segment: Continuous Positive Airway Pressure (CPAP) Devices
Market Share in 2025: 54.6%
By Applications
Fastest-Growing Segment: COPD
CAGR: 7.2% (2026–2034)
By End-Users
Leading Segment: Home Care
Market Share in 2025: 43.7%
Download a Free Sample To learn more about this report,
Positive Airway Pressure Devices Market Trends
Growing Adoption of Connected and Personalized PAP Devices
The positive airway pressure devices market is increasingly shifting toward connected devices that combine therapy delivery with digital monitoring and personalized treatment support. Manufacturers are integrating AI, machine learning, cloud connectivity, and mobile applications to improve therapy comfort, adherence, and monitoring. These technologies allow clinicians and patients to access therapy information remotely and support more individualized sleep apnea management.
In early 2026, ResMed introduced Smart Comfort, an FDA-cleared AI-enabled feature designed to recommend personalized comfort settings to help patients start and remain on CPAP therapy.
Expansion of Home-Based Sleep Therapy
Another important positive airway pressure devices market trend is the growing shift toward home-based diagnosis and treatment. Smaller, quieter, connected, and easier-to-use PAP devices are supporting treatment outside traditional clinical settings. Home-based care can improve convenience and access while enabling remote monitoring of therapy adherence and outcomes, particularly as healthcare systems increasingly emphasize decentralized respiratory and sleep care.
In July 2026, Resvent received FDA 510(k) clearance for its RXiBreeze 20C PAP system for treating obstructive sleep apnea in adults in home, hospital, and institutional environments.
Positive Airway Pressure Devices Market Dynamics
Market Drivers
Rising Prevalence and Diagnosis of Sleep Apnea
The increasing diagnosis of obstructive sleep apnea is driving demand for positive airway pressure devices, particularly CPAP systems. PAP therapy remains a standard treatment option for obstructive sleep apnea, while greater awareness and access to sleep testing are encouraging more patients to seek treatment. The availability of home sleep testing and different PAP modalities is also improving access to therapy.
In 2026, updated clinical guidance continued to recommend CPAP, APAP, and BPAP as established PAP treatment options for adults with obstructive sleep apnea, supporting continued demand for these devices.
Market Restraints
Challenges With Long-Term Patient Adherence
Patient adherence remains an important restraint for the positive airway pressure devices market because some users experience discomfort, mask-related problems, pressure intolerance, or difficulty adjusting to therapy. Inconsistent use can reduce treatment effectiveness and may discourage long-term device utilization. Manufacturers therefore need to improve comfort, usability, and individualized therapy settings to support sustained use.
In April 2025, a peer-reviewed study using cloud-based monitoring found that adherence remained a significant issue among PAP users, highlighting the importance of continued monitoring and patient support during long-term therapy.
Market Opportunities
Expansion of Remote Monitoring and Home-Based PAP Therapy
The growing use of home-based PAP initiation and remote monitoring is creating opportunities for device manufacturers to develop connected systems that support treatment outside traditional sleep laboratories. Cloud-based data can help clinicians monitor therapy usage and effectiveness, while telemedicine and digital applications can provide timely follow-up and patient support. These capabilities can improve convenience and expand access to sleep-disorder treatment.
In 2025, clinical research demonstrated the use of cloud-based monitoring to track PAP adherence, apnea-hypopnea index, and mask leakage over an extended period, highlighting the value of connected therapy management.
Market Challenges
Balancing Advanced Features With Affordability and Usability
Manufacturers face the challenge of incorporating connectivity, automated pressure adjustment, digital monitoring, and other advanced features while keeping devices comfortable, reliable, and affordable. More sophisticated systems can increase development and manufacturing complexity, while patients still require simple interfaces, effective masks, and convenient therapy. Regulatory requirements for connected and AI-enabled medical devices also add complexity to product development.
In August 2026, the FDA continued to classify positive airway pressure systems as Class II medical devices, reflecting the regulatory requirements manufacturers must meet for the safety and performance of PAP systems.
Positive Airway Pressure Devices Market Segmentation Analysis
By Product Type
Continuous Positive Airway Pressure (CPAP) Devices Segment Dominated the Market with 54.6% Share in 2025
The continuous positive airway pressure (CPAP) devices segment dominated the positive airway pressure devices market with a 54.6% share in 2025, reaching USD 1.58 billion, and is projected to grow at a CAGR of 6.3% during 2026–2034. Automatic positive airway pressure (APAP) devices accounted for a 27.8% share, reaching USD 0.81 billion, and are projected to grow at a CAGR of 7.4%, while bilevel positive airway pressure (BiPAP) devices represented a 17.6% share, reaching USD 0.51 billion, with a CAGR of 6.9%.
CPAP devices remain widely adopted because they provide consistent airway pressure throughout sleep and are commonly used for obstructive sleep apnea treatment. APAP devices are gaining importance because they automatically adjust pressure according to changing breathing patterns. BiPAP devices also remain important for patients requiring different pressure levels during inhalation and exhalation.
Request Customization to receive a tailored report.
By Applications
COPD Segment is Projected to Grow at a CAGR of 7.2%
The COPD segment accounted for a 13.3% share of the positive airway pressure devices market in 2025, reaching USD 0.39 billion, and is projected to grow at a CAGR of 7.2% during 2026–2034. Obstructive sleep apnea dominated the market with a 68.2% share, reaching USD 1.98 billion, and is projected to grow at a CAGR of 6.7%, while respiratory failures accounted for an 18.5% share, reaching USD 0.54 billion, with a CAGR of 6.9%.
The growing use of positive airway pressure therapy in COPD management is supporting demand for specialized respiratory support. Obstructive sleep apnea remains the primary application because PAP therapy is widely used to maintain airway patency during sleep. Respiratory failure applications are also benefiting from the increasing use of non-invasive ventilation and improvements in respiratory care.
By End-Users
Home Care Segment Dominated the Market with 43.7% Share in 2025
The home care segment dominated the positive airway pressure devices market with a 43.7% share in 2025, reaching USD 1.27 billion, and is projected to grow at a CAGR of 7.6% during 2026–2034. Hospitals accounted for a 34.7% share, reaching USD 1.01 billion, and are projected to grow at a CAGR of 6.2%, while sleep laboratories represented a 21.6% share, reaching USD 0.63 billion, with a CAGR of 6.5%.
Home-based PAP therapy is becoming increasingly important because it provides greater convenience and allows patients to continue long-term treatment outside clinical settings. Hospitals remain important for diagnosis, initiation of therapy, and management of complex respiratory conditions. Sleep laboratories continue to support patient evaluation, titration, diagnosis, and monitoring of sleep-related breathing disorders.
Speak to an Analyst to discuss market opportunities.
Positive Airway Pressure Devices Market Regional Outlook
North America Positive Airway Pressure Devices Market Analysis
North America dominated the positive airway pressure devices market with a 42.5% share in 2025, reaching USD 1.23 billion, and is projected to grow at a CAGR of 6.4% during 2026–2034. The region's leading position is supported by the high prevalence and diagnosis of sleep apnea, established sleep-care infrastructure, and strong adoption of CPAP and other PAP therapies. Growing awareness of sleep-related breathing disorders and increasing use of connected home-based therapy are also supporting regional market growth.
United States Positive Airway Pressure Devices Market Insights
The US market is supported by high awareness of sleep apnea, established sleep diagnostic facilities, and widespread adoption of CPAP and other positive airway pressure therapies. Increasing demand for home-based treatment, connected devices, and remote therapy monitoring is also contributing to market expansion.
Canada Positive Airway Pressure Devices Market Insights
Canada's market is supported by increasing awareness and diagnosis of sleep-related breathing disorders and growing demand for home-based PAP therapy. Improving access to sleep diagnostic services and increasing adoption of advanced respiratory devices are also supporting market development.
Unlock Regional Insights to access country-level data, & regional trends.
Europe Positive Airway Pressure Devices Market Analysis
Europe accounted for a 27.3% share of the positive airway pressure devices market in 2025, reaching USD 0.79 billion, and is projected to grow at a CAGR of 6.1% during 2026–2034. Growth is supported by increasing diagnosis of sleep apnea, expanding sleep-care services, and growing adoption of advanced PAP devices. Rising healthcare expenditure and increasing awareness of the health consequences associated with untreated sleep disorders are also contributing to regional expansion.
United Kingdom Positive Airway Pressure Devices Market Insights
The UK market is supported by increasing diagnosis and treatment of obstructive sleep apnea and growing demand for home-based PAP therapy. Expanding access to sleep services and increasing use of digitally connected respiratory devices are also supporting market growth.
Germany Positive Airway Pressure Devices Market Insights
Germany's market benefits from established healthcare infrastructure, increasing awareness of sleep-related breathing disorders, and growing adoption of PAP therapy. Demand for advanced and comfortable respiratory devices is supporting the expansion of positive airway pressure treatment.
Asia Pacific Positive Airway Pressure Devices Market Analysis
Asia Pacific accounted for a 20.4% share of the positive airway pressure devices market in 2025, reaching USD 0.59 billion, and is projected to grow at the fastest CAGR of 8.2% during 2026–2034. Growth is supported by increasing healthcare expenditure, rising awareness of sleep apnea, improving diagnostic infrastructure, and growing adoption of home-based respiratory care. Expanding healthcare access and increasing availability of advanced PAP devices are also supporting regional market development.
Japan Positive Airway Pressure Devices Market Insights
Japan's market is supported by an aging population, established healthcare infrastructure, and increasing awareness of sleep-related breathing disorders. Growing demand for convenient home-based treatment and advanced PAP technologies is also contributing to market growth.
China Positive Airway Pressure Devices Market Insights
China's market benefits from a large patient population, increasing healthcare expenditure, and growing awareness of sleep apnea and respiratory disorders. Improvements in diagnostic infrastructure and increasing adoption of home-based PAP devices are supporting market expansion.
Middle East and Africa Positive Airway Pressure Devices Market Analysis
The Middle East and Africa accounted for a 4.0% share of the positive airway pressure devices market in 2025, reaching USD 0.12 billion, and is projected to grow at a CAGR of 6.5% during 2026–2034. Growth is supported by improving healthcare infrastructure, increasing awareness of sleep-related breathing disorders, and rising demand for respiratory care technologies. Expansion of specialized healthcare services and greater access to advanced medical devices are also supporting regional development.
UAE Positive Airway Pressure Devices Market Insights
The UAE market is supported by advanced healthcare infrastructure, increasing awareness of sleep disorders, and growing demand for modern respiratory treatment technologies. Expanding sleep-care services and increasing adoption of home-based PAP therapy are creating opportunities for market growth.
Africa Positive Airway Pressure Devices Market Insights
Africa's market is supported by improving healthcare infrastructure, increasing awareness of respiratory and sleep-related disorders, and expanding access to medical devices. Growing healthcare investments and gradual development of sleep diagnostic and treatment services are supporting the adoption of positive airway pressure devices.
Positive Airway Pressure Devices Market Competitive Landscape
The positive airway pressure devices market is competitive, with major companies focusing on CPAP, APAP, and BiPAP technologies, patient comfort, connected therapy, remote monitoring, and home-based respiratory care. ResMed Corporation, Royal Philips N.V., and Fisher & Paykel Healthcare Corporation Limited are among the prominent players, with companies investing in advanced PAP technologies and digital solutions to improve treatment effectiveness and patient adherence. ResMed, for example, offers connected PAP devices with digital health capabilities, while Fisher & Paykel Healthcare focuses on PAP devices, masks, and humidification technologies for sleep-disordered breathing.
ResMed Corporation
ResMed is a leading player in the positive airway pressure devices market, with a broad portfolio of CPAP, APAP, and bilevel devices supported by digital health technologies. The company focuses on improving patient comfort, therapy adherence, remote monitoring, and personalized treatment through connected PAP systems and digital platforms.
In 2026, ResMed continued expanding its connected sleep and respiratory care portfolio, strengthening its focus on digital monitoring, personalized therapy, and home-based patient care.
List of Key and Emerging Players in Positive Airway Pressure Devices Market
ResMed Corporation
Royal Philips N.V.
3B Medical Corporation
Fisher & Paykel Healthcare Corporation Limited
Drive DeVilbiss Healthcare Inc.
Somnetics International Corporation
Heyer-Schulte Medical Corp.
Genstar Technologies LLC
BMC Medical Inc.
Apex Medical Corporation
Armstrong Medical Industries Inc.
Curative Medical Corporation
Compumedics Corporation Limited
CareFusion Corporation
Mercury Medical Inc.
Khayat Medical Industries S.A.R.L
Vyaire Medical Inc.
Teijin Limited
Medtronic PLC
Servona AG
Key Industry Developments
May 2026: ResMed launched the AirSense 12 platform featuring enhanced digital health capabilities, AI-powered therapy support, and improved patient connectivity for obstructive sleep apnea treatment.
February 2026: Fisher & Paykel Healthcare expanded its home respiratory care portfolio with new PAP mask technologies designed to improve patient comfort, fit, and long-term therapy adherence.
October 2025: ResMed introduced new AirFitTM mask solutions with upgraded cushion technology to improve comfort, reduce air leakage, and enhance positive airway pressure therapy outcomes.
June 2025: React Health expanded its sleep therapy portfolio by launching new CPAP and BiPAP devices with cloud-based patient monitoring and remote therapy management capabilities.
Report Scope
Comments
No comment